National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees for the Norton Company in Worcester, MA, To Be Included in the Special Exposure Cohort, 27551-27552 [E9-13662]

Download as PDF Federal Register / Vol. 74, No. 110 / Wednesday, June 10, 2009 / Notices 27551 Intermediary licenses have been reissued by the Federal Maritime Commission pursuant to section 19 of the Shipping Act of 1984 (46 U.S.C. Chapter 409) and the regulations of the Commission pertaining to the licensing of Ocean Transportation Intermediaries, 46 CFR Part 515. License No. Name/address Date reissued 001593F ............................................................ 013172N ........................................................... Robertson Forwarding Co., Inc., 4469 NW 97th Ave., Miami, FL 33178 ......... Yung Hoon Kim, dba Conex International, 20695 South Western Ave., Suite 136, Torrance, CA 90501. FEDERAL MARITIME COMMISSION Ocean Transportation Intermediary License Reissuances Notice is hereby given that the following Ocean Transportation erowe on PROD1PC63 with NOTICES Sandra L. Kusumoto, Director, Bureau of Certification and Licensing. [FR Doc. E9–13639 Filed 6–9–09; 8:45 am] Name: Cargonline (USA) Inc. Address: 245 E. Main Street, Ste. 112, Alhambra, CA 91801. Date Revoked: May 21, 2009. Reason: Failed to maintain a valid BILLING CODE 6730–01–P bond. License Number: 004084F. FEDERAL MARITIME COMMISSION Name: Glory Express, Inc. Address: 17420 S. Avalon Blvd., Ste. Ocean Transportation Intermediary 202, Carson, CA 90746. License Revocations Date Revoked: May 22, 2009. Reason: Failed to maintain a valid The Federal Maritime Commission bond. hereby gives notice that the following License Number: 017911N. Ocean Transportation Intermediary Name: Kasy Logistics Co., Ltd. licenses have been revoked pursuant to Address: 355 S. Lemon Ave., #N, section 19 of the Shipping Act of 1984 Walnut, CA 91789. (46 U.S.C. Chapter 409) and the Date Revoked: May 29, 2009. regulations of the Commission Reason: Surrendered license pertaining to the licensing of Ocean voluntarily. Transportation Intermediaries, 46 CFR License Number: 016503NF. Part 515, effective on the corresponding Name: Lukini Shipping Inc. date shown below: Address: One Cross Island Plaza, Ste. License Number: 000692F. 203d, Rosedale, NY 11422. Name: A. R. Savage & Son, Inc. Date Revoked: May 27, 2009. Address: 701 Harbour Post Dr., Reason: Failed to maintain valid Tampa, FL 33602. bonds. Date Revoked: May 27, 2009. License Number: 002145F. Reason: Failed to maintain a valid Name: Henry Juliusburger DBA bond. Nautique-Worldwide. License Number: 017799NF. Address: 55 New Montgomery St., Name: Alpha Freight & Transport Ste. 514, San Francisco, CA 94105. International, Inc. Date Revoked: May 22, 2009. Address: 3508 NW 114th Ave., Ste. Reason: Failed to maintain a valid 205, Doral, FL 33178. bond. Date Revoked: May 27, 2009. License Number: 013797N. Reason: Surrendered license Name: Kenneth Bola Obatusin DBA voluntarily. Global Freightways (USA), Ltd. License Number: 018583NF. Address: 10630 Riggs Hill Rd., Bldg. Name: Astron Distribution, Inc. R, Jessup, MD 20794. Address: 349 NW 16th Street, Ste. Date Revoked: May 29, 2009. 107, Belle Glade, FL 33430. Reason: Failed to maintain a valid Date Revoked: May 27, 2009. bond. Reason: Failed to maintain valid License Number: 016484N. bonds. Name: Kenny International USA, Inc. License Number: 018878N. DBA KTL (USA) International. Name: BTL Group, Inc. Dba E–World Address: 145–18 156th Street, Rm. #1, Cargo, Inc. Jamaica, NY 11434. Address: 7910 SO. 3500 E., Ste. B, Salt Date Revoked: April 6, 2009. Lake, UT 84121. Reason: Surrendered license Date Revoked: May 6, 2009. voluntarily. Reason: Surrendered license License Number: 020066N. voluntarily. Name: Manila Forwarders License Number: 021167N. Corporation. VerDate Nov<24>2008 15:18 Jun 09, 2009 Jkt 217001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 May 10, 2009. May 6, 2009. Address: 8241 Backlick Rd., Ste. B, Lorton, VA 22079. Date Revoked: May 29, 2009. Reason: Failed to maintain a valid bond. License Number: 000334F. Name: Perryman Mojonier Company. Address: 9720 S. La Cienega Blvd., Inglewood, CA 90301. Date Revoked: May 29, 2009. Reason: Failed to maintain a valid bond. Sandra L. Kusumoto, Director, Bureau of Certification and Licensing. [FR Doc. E9–13651 Filed 6–9–09; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health; Decision To Evaluate a Petition To Designate a Class of Employees for the Norton Company in Worcester, MA, To Be Included in the Special Exposure Cohort AGENCY: National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. SUMMARY: HHS gives notice as required by 42 CFR 83.12(e) of a decision to evaluate a petition to designate a class of employees for the Norton Company in Worcester, Massachusetts, to be included in the Special Exposure Cohort under the Energy Employees Occupational Illness Compensation Program Act of 2000. The initial proposed definition for the class being evaluated, subject to revision as warranted by the evaluation, is as follows: Facility: Norton Company. Location: Worcester, Massachusetts. Job Titles and/or Job Duties: All Atomic Weapons Employer employees. Period of Employment: January 1, 1945 through December 31, 1957. E:\FR\FM\10JNN1.SGM 10JNN1 27552 Federal Register / Vol. 74, No. 110 / Wednesday, June 10, 2009 / Notices FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone 513– 533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. teleconference dial-in. If you have special needs for the meeting, please contact (202) 690–7151. Judith Sparrow, Office of Programs and Coordination, Office of the National Coordinator for Health Information Technology. [FR Doc. E9–13630 Filed 6–9–09; 8:45 am] BILLING CODE 4150–45–P Christine M. Branche, Acting Director, National Institute for Occupational Safety and Health. [FR Doc. E9–13662 Filed 6–9–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–19–P Proposed Collection; Comment Request; Investigator Registration and Financial Disclosure for Investigational Trials in Cancer Treatment (NCI) National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the National Coordinator for Health Information Technology; HIT Standards Committee Meeting ACTION: Announcement of meeting. SUMMARY: This notice announces the second meeting of the HIT Standards Committee in accordance with the Federal Advisory Committee Act (Pub. L. No. 92–463, 5 U.S.C., App.). DATES: June 23, 2009, from 9 a.m. to 12 p.m. [Eastern] ADDRESSES: The Omni Shoreham Hotel, 2500 Calvert Street, NW., Washington, DC 20008, Diplomat Ballroom. FOR FURTHER INFORMATION CONTACT: https://healthit.hhs.gov. SUPPLEMENTARY INFORMATION: The meeting will include presentations from the HIT Standards Committee Workgroups. The meeting is a Web-based meeting with SUMMARY: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute, the National Cancer Institute (NIH) will publish periodic summaries to the Office of Management and Budget (OMB) for review and approval. Proposed Collection: Title: Investigator Registration and Financial Disclosure for Investigational Trials in Cancer Treatment (NCI). Type of Information Collection Request: Existing Collection in use without an OMB Control Number. Need and Use of Information Collection: Food and Drug Administration (FDA) regulations require sponsors to obtain information from the investigator before permitting the investigator to begin participation in investigational studies. The National Cancer Institute (NCI), as a sponsor of investigational drug trials, has the responsibility to assure the FDA that investigators in its clinical trials program are qualified by training and experience as appropriate experts to investigate the drug. In order to fulfill these requirements, a standard Statement of Investigator (FDA Form 1572 modified), Supplemental Investigator Data Form, Financial Disclosure Form and Curriculum vitae (CV) are required. The data obtained from these forms allows the NCI to evaluate the qualifications of the investigator, identify appropriate personnel to receive shipment of investigational agent, ensure supplies are not diverted for inappropriate protocol or patient use and identify financial conflicts of interest. Comparisons are done with the intention of ensuring protocol, patient safety and drug compliance for patient and drug compliance for patient safety and protections. Frequency of Response: Annually. Affected Public: Public sector, businesses other for-profit. Federal agencies or employees, non-profit institutions and a very small number of private practice physicians. Type of Respondents: Health care investigators. The annual reporting burden is limited to those physicians who choose to participate in NCI sponsored investigational trials to identify new medicinal agents to treat and relieve those patients suffering from cancer. It is estimated that the total annual burden will be 8,564 hours, and include 17,128 investigators, for this project (see Table 1). TABLE 1—ESTIMATES OF ANNUAL BURDEN Number of respondents Type of respondents Form Investigators and Designee ... Statement of Investigator ..... Supplemental Investigator .... Financial Disclosure ............. ............................................... erowe on PROD1PC63 with NOTICES Totals .............................. There is no capital, operating or maintenance costs to report. Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed VerDate Nov<24>2008 15:18 Jun 09, 2009 Jkt 217001 17,128 17,128 17,128 17,128 Frequency of response Average time per response 1 1 1 ........................ 0.25 (15 minutes) ................. 0.167 (10 minutes) ............... 0.083 (5 minutes) ................. ............................................... collection of information; including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Total hour burden 4,282 2,855 1,427 8,564 FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Charles L. Hall, Jr., Chief, Pharmaceutical Management Branch, Cancer Therapy Evaluation Program, Division of the Cancer Treatment and Diagnosis, and Centers, National Cancer Institute, Executive Plaza North, Room 7148, 9000 Rockville Pike, Bethesda, MD 20892 or call nontoll-free number 301–496–5725 or E- E:\FR\FM\10JNN1.SGM 10JNN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 74, Number 110 (Wednesday, June 10, 2009)]
[Notices]
[Pages 27551-27552]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-13662]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; Decision 
To Evaluate a Petition To Designate a Class of Employees for the Norton 
Company in Worcester, MA, To Be Included in the Special Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HHS gives notice as required by 42 CFR 83.12(e) of a decision 
to evaluate a petition to designate a class of employees for the Norton 
Company in Worcester, Massachusetts, to be included in the Special 
Exposure Cohort under the Energy Employees Occupational Illness 
Compensation Program Act of 2000. The initial proposed definition for 
the class being evaluated, subject to revision as warranted by the 
evaluation, is as follows:
    Facility: Norton Company.
    Location: Worcester, Massachusetts.
    Job Titles and/or Job Duties: All Atomic Weapons Employer 
employees.
    Period of Employment: January 1, 1945 through December 31, 1957.

[[Page 27552]]


FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also be submitted by e-mail to OCAS@CDC.GOV.

Christine M. Branche,
Acting Director, National Institute for Occupational Safety and Health.
[FR Doc. E9-13662 Filed 6-9-09; 8:45 am]
BILLING CODE 4163-19-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.